Nanotoxicologies

Health written question – answered on 18th April 2013.

Alert me about debates like this

Photo of Graham Brady Graham Brady Chair, Conservative Party 1922 Committee

To ask the Secretary of State for Health what assessment his Department has made of the potential use of analytical electron microscopy in studies of orphan diseases which may be a consequence of nanotoxicologies; and what representations his Department has received on the regulation of nanotoxicologies.

Photo of Norman Lamb Norman Lamb The Minister of State, Department of Health

The Department has not made any assessment of the potential use of analytical electron microscopy in studies of orphan diseases which may be a consequence of nanotoxicologies.

The Medicines and Healthcare products Regulatory Agency (MHRA) believes that current European Union regulations for medicines and medical devices are sufficiently stringent and broad in scope to cover risks associated with nanotechnologies. The MHRA will keep nanotechnology developments under review and will work with the European Commission, European Medicines Agency and the European Medical Devices Expert Working Group to assess the relevant existing regulations with regard to nanotechnologies.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.